Hansra Nina, Arya Shruti, Quick Michael W
Department of Biological Sciences, University of Southern California, Los Angeles, California 90089-2520, USA.
J Neurosci. 2004 Apr 21;24(16):4082-7. doi: 10.1523/JNEUROSCI.0664-04.2004.
Plasma membrane neurotransmitter transporters determine in part the concentration, time course, and diffusion of extracellular transmitter. Much has been learned about how substrate translocation through the transporter occurs; however, the precise way in which transporter structure maps onto transporter function has not yet been fully elucidated. Here, biochemical and electrophysiological approaches were used to test the hypothesis that intracellular domains of the rat brain GABA transporter (GAT1) contribute to the transport process. Injection of a peptide corresponding to the presumed fourth intracellular loop of the transporter (IL4) into oocytes expressing GAT1 greatly reduced both forward and reverse transport and reduced the transport rate in a dose-dependent manner. Coinjection of the IL4 peptide with a peptide corresponding to the N-terminal cytoplasmic tail of GAT1 reversed the IL4-mediated inhibition; this reversal, and direct binding between these two domains, was prevented by mutagenesis of charged residues in either the IL4 or N-terminal domains. Furthermore, syntaxin 1A, a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein that inhibits GAT1 transport rates via interactions with the N-terminal tail of GAT1 was unable to regulate the GAT1 IL4 mutant. Together, these data suggest a model in which the GAT1 IL4 domain serves as a barrier for transport, and this barrier can be regulated through intra-molecular and inter-molecular interactions.
质膜神经递质转运体部分决定了细胞外递质的浓度、时程和扩散。关于底物如何通过转运体进行转运,我们已经了解了很多;然而,转运体结构与转运体功能的确切对应方式尚未完全阐明。在这里,采用生化和电生理方法来检验大鼠脑γ-氨基丁酸转运体(GAT1)的细胞内结构域有助于转运过程这一假说。将对应于该转运体假定的第四个细胞内环(IL4)的肽注射到表达GAT1的卵母细胞中,可大幅降低正向和反向转运,并以剂量依赖方式降低转运速率。将IL4肽与对应于GAT1 N端胞质尾的肽共同注射可逆转IL4介导的抑制作用;通过对IL4或N端结构域中带电荷残基进行诱变,可阻止这种逆转以及这两个结构域之间的直接结合。此外, syntaxin 1A是一种可溶性N-乙基马来酰亚胺敏感因子附着蛋白受体(SNARE)蛋白,它通过与GAT1的N端尾相互作用来抑制GAT1的转运速率,但无法调节GAT1 IL4突变体。这些数据共同表明了一个模型,即GAT1的IL4结构域充当转运的屏障,并且这种屏障可通过分子内和分子间相互作用进行调节。